The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
10:45 a.m. Regulatory Requirements Affecting Marijuana
J. Richard Crout, Crout Consulting
11:15 a.m. Marinol and the Market
Robert E. Dudley, Unimed Pharmaceuticals, Inc.
11:45 a.m. Development of Cannabis-based Therapeutics
Dave Pate, HortaPharm, B.V.
12:15 p.m. LUNCH
1:30 p.m. Alternative Drug Delivery Technologies for the Therapeutic Use of Marijuana
Phyllis I. Gardner, ALZA Corporation, Stanford University
2:00 p.m. Delivery of Analgesics via the Respiratory Track
Reid M. Rubsamen, Aradigm Corporation
2:30 p.m. Current Concepts for Delivery of THC
Mahendra G. Dedhiya, Roxanne Laboratories, Inc.
3:00 p.m. D9-THC-Hemisuccinate in Suppository Formulation: An Alternative to Oral and Smoked
THC Mahmoud A. ElSohly, University of Mississippi, ElSohly Laboratories, Inc.
3:30 p.m. Concluding Remarks
John A. Benson, Jr., IOM Study Investigator, Oregon Health Sciences University
3:45 p.m. ADJOURN